These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25059214)

  • 1. Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration.
    Zhao GY; Di DH; Wang B; Huang X; Xu YJ
    Inflammation; 2015 Apr; 38(2):718-27. PubMed ID: 25059214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentosan polysulfate regulates hepcidin 1-facilitated formation and function of osteoclast derived from canine bone marrow.
    Wijekoon S; Sunaga T; Wang Y; Mwale C; Kim S; Okumura M
    PLoS One; 2022; 17(3):e0265596. PubMed ID: 35299233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lowering iron level protects against bone loss in focally irradiated and contralateral femurs through distinct mechanisms.
    Zhang J; Zheng L; Wang Z; Pei H; Hu W; Nie J; Shang P; Li B; Hei TK; Zhou G
    Bone; 2019 Mar; 120():50-60. PubMed ID: 30304704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin-induced reduction in iron content and PGC-1β expression negatively regulates osteoclast differentiation to play a protective role in postmenopausal osteoporosis.
    Zhang H; Wang A; Shen G; Wang X; Liu G; Yang F; Chen B; Wang M; Xu Y
    Aging (Albany NY); 2021 Apr; 13(8):11296-11314. PubMed ID: 33820875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on the effect of hepcidin overexpression on osteoclasts and bone mass in iron accumulation mice].
    Zhang H; Yang F; Wang AF; Jia P; Wang X; Yuan Y; Zhang P; Xu YJ
    Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(15):1183-1188. PubMed ID: 29690733
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of ferric ion on the differentiation of osteoclast and bone resorption].
    Jia P; He YF; Gao C; Du HB; Hu ZY; Feng XQ; Li BY; Zhang ZL; Xu YJ; Lin H
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2214-8. PubMed ID: 23158430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin protects against iron overload-induced inhibition of bone formation in zebrafish.
    Jiang Y; Chen B; Yan Y; Zhu GX
    Fish Physiol Biochem; 2019 Feb; 45(1):365-374. PubMed ID: 30361820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepcidin on intracellular calcium in human osteoblasts.
    Li GF; Xu YJ; He YF; Du BC; Zhang P; Zhao DY; Yu C; Qin CH; Li K
    Mol Cell Biochem; 2012 Jul; 366(1-2):169-74. PubMed ID: 22555956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis.
    Sow FB; Florence WC; Satoskar AR; Schlesinger LS; Zwilling BS; Lafuse WP
    J Leukoc Biol; 2007 Oct; 82(4):934-45. PubMed ID: 17609338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
    Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
    Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin is an endogenous protective factor for osteoporosis by reducing iron levels.
    Zhang P; Wang S; Wang L; Shan BC; Zhang H; Yang F; Zhou ZQ; Wang X; Yuan Y; Xu YJ
    J Mol Endocrinol; 2018 May; 60(4):297-306. PubMed ID: 29563156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local hepcidin increased intracellular iron overload via the degradation of ferroportin in the kidney.
    Pan S; Qian ZM; Cui S; Zhao D; Lan W; Wang X; Chen X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):322-327. PubMed ID: 31761321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin, iron, and bacterial infection.
    Barton JC; Acton RT
    Vitam Horm; 2019; 110():223-242. PubMed ID: 30798814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AP-002: A novel inhibitor of osteoclast differentiation and function without disruption of osteogenesis.
    Wang Y; Mei Y; Song Y; Bachus C; Sun C; Sheshbaradaran H; Glogauer M
    Eur J Pharmacol; 2020 Dec; 889():173613. PubMed ID: 33007291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of hepcidin - the master regulator of iron metabolism.
    Vyoral D; Jiri Petrak
    Pharmacol Res; 2017 Jan; 115():242-254. PubMed ID: 27867027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells.
    Wu SH; Zhong ZM; Chen JT
    Int J Med Sci; 2012; 9(9):801-7. PubMed ID: 23136544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
    Cao B; Dai X; Wang W
    J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts.
    Zhang DL; Senecal T; Ghosh MC; Ollivierre-Wilson H; Tu T; Rouault TA
    Blood; 2011 Sep; 118(10):2868-77. PubMed ID: 21700773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methylglyoxal on RANKL-induced osteoclast differentiation in RAW264.7 cells.
    Suh KS; Chon S; Jung WW; Choi EM
    Chem Biol Interact; 2018 Dec; 296():18-25. PubMed ID: 30217477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.